← Back to Search

Other

Healthy Volunteer MRI for Healthy Subjects

N/A
Waitlist Available
Led By Deshan Yang, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 6 months
Awards & highlights

Study Summary

This trial aims to study how organs and tissues move in the abdomen and use math to predict their motion.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
abdominal respiratory motion as measured by MRI
gastrointestinal motility motion as measured by MRI
inter-fractional motion as measured by MRI

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy Volunteer MRIExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,044 Total Patients Enrolled
Deshan Yang, PhDPrincipal InvestigatorDuke University Health System (DUHS)
John Ginn, PhDPrincipal InvestigatorDuke University Health System (DUHS)

Media Library

MRI (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05674851 — N/A
Healthy Subjects Research Study Groups: Healthy Volunteer MRI
Healthy Subjects Clinical Trial 2023: MRI Highlights & Side Effects. Trial Name: NCT05674851 — N/A
MRI (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05674851 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrollment in this trial at present?

"The clinicaltrials.gov database presents evidence that this particular trial, which was first advertised on February 1st 2023, is not currently enrolling any new patients. However, there are 787 other studies actively seeking participants at this time."

Answered by AI
~17 spots leftby May 2026